Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. (Q40642496)
Jump to navigation
Jump to search
scientific article published on June 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. |
scientific article published on June 2002 |
Statements
Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis (English)
Andreas Evdokiou
Stelios Bouralexis
Fugui Chai
Shelley Hay
Mark Clayer
David M Findlay
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference